{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:51:12Z","timestamp":1757620272619,"version":"3.44.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Analysis of the Efficacy and Safety of Azacitidine in Maintenance Therapy for Acute Myeloid Leukemia","award":["(23)0379","(23)0379"],"award-info":[{"award-number":["(23)0379","(23)0379"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14653-4","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T14:37:08Z","timestamp":1753799828000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk factor analysis and predictive model development for secondary failure of platelet recovery following allogeneic hematopoietic stem cell transplantation"],"prefix":"10.1186","volume":"25","author":[{"given":"Xiru","family":"Peng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,29]]},"reference":[{"issue":"5","key":"14653_CR1","doi-asserted-by":"publisher","first-page":"599","DOI":"10.6004\/jnccn.2020.0021","volume":"18","author":"A Saad","year":"2020","unstructured":"Saad A, de Lima M, Anand S, et al. Hematopoietic cell transplantation, version 2.2020, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2020;18(5):599\u2013634.","journal-title":"J Natl Compr Canc Netw"},{"issue":"suppl 1","key":"14653_CR2","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/stem.5530140734","volume":"14","author":"RA Nash","year":"1996","unstructured":"Nash RA, Gooley T, Davis C, Appelbaum FR. The problem of thrombocytopenia after hematopoietic stem cell transplantation. Stem Cells. 1996;14(suppl 1):261\u201373.","journal-title":"Stem Cells"},{"issue":"12","key":"14653_CR3","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.jtct.2024.09.005","volume":"30","author":"P Kongtim","year":"2024","unstructured":"Kongtim P, Vittayawacharin P, Zou J, Srour S, Shaffer B, Shapiro RM, Varma A, McGuirk J, Dholaria BR, McCurdy SR, DeZern AE, Bejanyan N, Bashey A, Furst S, Castagna L, Mariotti J, Ruggeri A, Bailen R, Teshima T, Xiao-Jun H, Bonfim C, Aung F, Cao K, Carpenter PA, Hamadani M, Askar M, Fernandez-Vina M, Girnita A, Ciurea SO. ASTCT consensus recommendations on testing and treatment of patients with Donor-specific Anti-HLA antibodies. Transpl Cell Ther. 2024;30(12):1139\u201354.","journal-title":"Transpl Cell Ther"},{"issue":"2","key":"14653_CR4","doi-asserted-by":"publisher","first-page":"74","DOI":"10.2991\/chi.d.200221.001","volume":"2","author":"M Remberger","year":"2020","unstructured":"Remberger M, Gr\u00f8nvold B, Ali M, Mattsson J, Egeland T, Lundin KU, Myhre A, Abrahamsen I, Heldal D, Dybedal I, Tj\u00f8nnfjord GE, Gedde-Dahl T, Fl\u00f8isand Y. The CD34 cell dose matters in hematopoietic stem cell transplantation with peripheral blood stem cells from sibling donors. Clin Hematol Int. 2020;2(2):74\u201381.","journal-title":"Clin Hematol Int"},{"key":"14653_CR5","doi-asserted-by":"publisher","first-page":"204062072412451","DOI":"10.1177\/20406207241245190","volume":"15","author":"Y Xie","year":"2024","unstructured":"Xie Y, Yang G, Pan L, Gan Z, Huang Y, Lai Y, Liu R. Development of a nomogram to predict the risk of secondary failure of platelet recovery in patients with \u03b2-thalassemia major after hematopoietic stem cell transplantation: a retrospective study. Ther Adv Hematol. 2024;15:20406207241245190.","journal-title":"Ther Adv Hematol"},{"issue":"4","key":"14653_CR6","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s11427-019-9594-7","volume":"63","author":"F Tang","year":"2020","unstructured":"Tang F, Xu Y, Chen H, Xu L, Zhang X, Wang Y, Liu Q, Wu D, Huang X. Comparison of the clinical outcomes of hematologic malignancies after myeloablative haploidentical transplantation with G-CSF\/ATG and posttransplant cyclophosphamide: results from the Chinese bone marrow transplantation registry group (CBMTRG). Sci China Life Sci. 2020;63(4):571\u201381.","journal-title":"Sci China Life Sci"},{"issue":"1","key":"14653_CR7","doi-asserted-by":"publisher","first-page":"84.e1","DOI":"10.1016\/j.bbmt.2020.10.008","volume":"27","author":"N El Jurdi","year":"2021","unstructured":"El Jurdi N, Rogosheske J, DeFor T, Bejanyan N, Arora M, Bachanova V, Betts B, He F, Holtan S, Janakiram M, Larson S, Maakaron J, Rashidi A, Warlick E, Wagner JE, Young JH, Weisdorf D, Brunstein CG. Prophylactic Foscarnet for Human Herpesvirus 6: Effect on Hematopoietic Engraftment after Reduced-Intensity Conditioning Umbilical Cord Blood Transplantation. Transplant Cell Ther. 2021;27(1):84.e1-84.e5.","journal-title":"Transplant Cell Ther."},{"key":"14653_CR8","doi-asserted-by":"publisher","first-page":"911174","DOI":"10.3389\/fimmu.2022.911174","volume":"13","author":"Y Man","year":"2022","unstructured":"Man Y, Lu Z, Yao X, Gong Y, Yang T, Wang Y. Recent advancements in poor graft function following hematopoietic stem cell transplantation. Front Immunol. 2022;13:911174.","journal-title":"Front Immunol"},{"issue":"5","key":"14653_CR9","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1182\/bloodadvances.2020002790","volume":"5","author":"Y Tang","year":"2021","unstructured":"Tang Y, Chen J, Liu Q, Chu T, Pan T, Liang J, He XF, Chen F, Yang T, Ma X, Wu X, Hu S, Cao X, Hu X, Hu J, Liu Y, Qi J, Shen Y, Ruan C, Han Y, Wu D. Low-dose decitabine for refractory prolonged isolated thrombocytopenia after HCT: a randomized multicenter trial. Blood Adv. 2021;5(5):1250\u20138.","journal-title":"Blood Adv"},{"issue":"6","key":"14653_CR10","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1182\/bloodadvances.2021004537","volume":"6","author":"A Prabahran","year":"2022","unstructured":"Prabahran A, Koldej R, Chee L, Ritchie D. Clinical features, pathophysiology, and therapy of poor graft function post-allogeneic stem cell transplantation. Blood Adv. 2022;6(6):1947\u201359.","journal-title":"Blood Adv"},{"issue":"1","key":"14653_CR11","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12916-022-02338-9","volume":"20","author":"Y Wang","year":"2022","unstructured":"Wang Y, Kong Y, Zhao HY, Zhang YY, Wang YZ, Xu LP, et al. Prophylactic NAC promoted hematopoietic reconstitution by improving endothelial cells after haploidentical HSCT: a phase 3, open-label randomized trial. BMC Med. 2022;20(1):140.","journal-title":"BMC Med"},{"issue":"7","key":"14653_CR12","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/sj.bmt.1704428","volume":"33","author":"KH Lee","year":"2004","unstructured":"Lee KH, Lee JH, Choi SJ, et al. Failure of trilineage blood cell reconstitution after initial neutrophil engraftment in patients undergoing allogeneic hematopoietic cell transplantation - frequency and outcomes. Bone Marrow Transpl. 2004;33(7):729\u201334.","journal-title":"Bone Marrow Transpl"},{"issue":"3","key":"14653_CR13","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1182\/blood.2021011281","volume":"138","author":"M Gooptu","year":"2021","unstructured":"Gooptu M, Romee R, St Martin A, et al. HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis. Blood. 2021;138(3):273\u201382.","journal-title":"Blood"},{"issue":"23","key":"14653_CR14","doi-asserted-by":"publisher","first-page":"8497","DOI":"10.1002\/cam4.4353","volume":"10","author":"WR Lv","year":"2021","unstructured":"Lv WR, Zhou Y, Xu J, Fan ZP, et al. Haploidentical donor transplant is associated with secondary poor graft function after allogeneic stem cell transplantation: a single-center retrospective study. Cancer Med. 2021;10(23):8497\u2013506.","journal-title":"Cancer Med"},{"issue":"3","key":"14653_CR15","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1053\/j.seminhematol.2018.08.004","volume":"56","author":"Y Kong","year":"2019","unstructured":"Kong Y. Poor graft function after allogeneic hematopoietic stem cell transplantation-an old complication with new insights. Semin Hematol. 2019;56(3):215\u201320.","journal-title":"Semin Hematol"},{"issue":"10","key":"14653_CR16","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1016\/j.bbmt.2020.06.003","volume":"26","author":"A Huang","year":"2020","unstructured":"Huang A, Zhao X, Li M, et al. Suppression of hematopoietic primitive cells in patients with secondary failure of platelet recovery after acute Graft-versus-Host disease. Biol Blood Marrow Transpl. 2020;26(10):1840\u201354.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"9","key":"14653_CR17","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1016\/j.bbmt.2016.06.003","volume":"22","author":"Y Akahoshi","year":"2016","unstructured":"Akahoshi Y, Kanda J, Gomyo A, et al. Risk factors and impact of secondary failure of platelet recovery after allogeneic stem cell transplantation. Biol Blood Marrow Transpl. 2016;22(9):1678\u201383.","journal-title":"Biol Blood Marrow Transpl"},{"key":"14653_CR18","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1053\/bbmt.2001.v7.pm11302549","volume":"7","author":"B Bruno","year":"2001","unstructured":"Bruno B, Gooley T, Sullivan KM, et al. Secondary failure of platelet recovery after hematopoietic stem cell transplantation. Biol Blood Marrow Transpl. 2001;7:154\u201362.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"8","key":"14653_CR19","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1007\/s00277-020-04155-7","volume":"99","author":"Z Li","year":"2020","unstructured":"Li Z, Lai Y, Zhang X, et al. Monosomal karyotype is associated with poor outcomes in patients with Philadelphia chromosome-negative acute lymphoblastic leukemia receiving chemotherapy but not allogeneic hematopoietic stem cell transplantation. Ann Hematol. 2020;99(8):1833\u201343.","journal-title":"Ann Hematol"},{"issue":"2","key":"14653_CR20","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/bjh.18855","volume":"202","author":"T Jo","year":"2023","unstructured":"Jo T, Arai Y, Oshima S, Kondo T, et al. Prognostic impact of complex and\/or monosomal karyotypes in post-transplant poor cytogenetic acute myeloid leukaemia: a quantitative approach. Br J Haematol. 2023;202(2):356\u201368.","journal-title":"Br J Haematol"},{"issue":"5","key":"14653_CR21","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jtct.2022.02.016","volume":"28","author":"HA Knaus","year":"2022","unstructured":"Knaus HA, Rottner T, Baumann CK, et al. Cytokine release syndrome during antithymocyte Globulin\/anti-T lymphocyte Globulin serotherapy for graft-versus-host disease prophylaxis before allogeneic hematopoietic stem cell transplantation: incidence and early clinical impact according to American society of transplantation and cellular therapy grading criteria[J]. Transplantation Cell Therapy. 2022;28(5):260. e1-260. e9.","journal-title":"Transplantation Cell Therapy"},{"key":"14653_CR22","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.3389\/fimmu.2019.02319","volume":"10","author":"R Greco","year":"2019","unstructured":"Greco R, Lorentino F, Nitti R, et al. Interleukin-6 as biomarker for acute GvHD and survival after allogeneic transplant with post-transplant cyclophosphamide. Front Immunol. 2019;10:2319.","journal-title":"Front Immunol"},{"issue":"10","key":"14653_CR23","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1016\/j.bbmt.2019.06.003","volume":"25","author":"M Nishimoto","year":"2019","unstructured":"Nishimoto M, Hirose A, Koh H, et al. Clinical impacts of using serum IL-6 level as an Indicator of cytokine release syndrome after HLA-Haploidentical transplantation with Post-Transplantation cyclophosphamide. Biol Blood Marrow Transpl. 2019;25(10):2061\u20139.","journal-title":"Biol Blood Marrow Transpl"},{"key":"14653_CR24","doi-asserted-by":"publisher","first-page":"940320","DOI":"10.3389\/fonc.2022.940320","volume":"12","author":"H Wang","year":"2022","unstructured":"Wang H, Qi J, Li X, et al. Prognostic value of thrombocytopenia in myelodysplastic syndromes after hematopoietic stem cell transplantation. Front Oncol. 2022;12:940320.","journal-title":"Front Oncol"},{"issue":"2","key":"14653_CR25","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.idc.2019.02.001","volume":"33","author":"RL Kao","year":"2019","unstructured":"Kao RL, Holtan SG. Host and graft factors impacting infection risk in hematopoietic cell transplantation. Infect Dis Clin North Am. 2019;33(2):311\u201329.","journal-title":"Infect Dis Clin North Am"},{"issue":"1","key":"14653_CR26","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12941-023-00653-4","volume":"22","author":"X Yang","year":"2023","unstructured":"Yang X, Zeng J, Yu X, et al. PCT, IL-6, and IL-10 facilitate early diagnosis and pathogen classifications in bloodstream infection. Ann Clin Microbiol Antimicrob. 2023;22(1):103.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"14653_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2021.106574","volume":"105","author":"S Li","year":"2021","unstructured":"Li S, Gu J, Nan W, et al. Procalcitonin and C-reactive protein predict infection in hematopoietic stem cell transplantation patients. Leuk Res. 2021;105: 106574.","journal-title":"Leuk Res"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14653-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14653-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14653-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T06:49:20Z","timestamp":1757314160000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14653-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,29]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14653"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14653-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"type":"electronic","value":"1471-2407"}],"subject":[],"published":{"date-parts":[[2025,7,29]]},"assertion":[{"value":"31 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants were reviewed and approved by the Center for Ethics in the First Hospital of Lanzhou University. Written informed consent was obtained from patient for the publication of any potentially identifiable images or data included in this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1233"}}